ID: h-ae112108
Hypothesis
GABAergic Hub Stabilization Through α5-Subunit Inverse Agonists
GABAergic Hub Stabilization Through α5-Subunit Inverse Agonists.
EvidencePending (0%)📖 0 cit🗣 1 debates✓ 5 support✗ 5 oppose
🧪 Overview
GABAergic Hub Stabilization Through α5-Subunit Inverse Agonists
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
flowchart TD
A["GABAergic Hub Stabilization<br/>Hypothesis Target"]
B["Pathway Dysregulation<br/>Cited Mechanism"]
C["Cellular Response<br/>Stress or Clearance Change"]
D["Neural Circuit Effect<br/>Synapse/Glia Vulnerability"]
E["Neurodegeneration<br/>Disease-Relevant Outcome"]
A --> B
B --> C
C --> D
D --> E
style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style B fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style E fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a⚖️ Evidence
⚖️ Evidence Matrix5 supports5 contradicts
Supports
Activity-dependent degeneration explains hub vulnerability - highly active neurons accumulate more pathology
Supports
α5 inverse agonists reduce excitotoxicity without cognitive impairment in preclinical models
Contradicts
RG1662 (α5 inverse agonist) failed in Down syndrome clinical trials - no cognitive benefit
Contradicts
Inverted U-shaped relationship: both excessive activity AND suppression alter amyloid dynamics
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — GABAERGIC
No curated PDB or AlphaFold mapping for GABAERGIC yet. Search RCSB →
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for GABAergic Hub Stabilization.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▲ 0.5%
Volatility
Low
0.0140
Events (7d)
2
Price History
▲11.9%💾 Resource Usage
LLM Tokens
47,826
$0.1435
Total Cost
$0.1435
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF we administer a selective GABA-A α5-subunit inverse agonist (e.g., MRK-016 at 10 mg/kg, i.p.) to adult C57BL/6J mice for 14 consecutive days, THEN we will observe significant stabilization of GABAe | ≥30% reduction in firing variability (CV-ISI) of GABAergic hub neurons in α5 inverse agonist-treated mice relative to vehicle-treated controls after 14 days of | — no observation — | pending | 0.65 |
| IF we perform chemogenetic inhibition (hM4Di) of GABAergic hub neurons specifically in the anterior cingulate cortex while concurrently administering an α5-subunit inverse agonist (RG1662, 20 mg/kg/da | Partial restoration (≥40%) of ACC-centered functional connectivity metrics to non-stressed baseline levels within 3 weeks of combined intervention, as assessed | — no observation — | pending | 0.55 |
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF we administer a selective GABA-A α5-subunit inverse agonist (e.g., MRK-016 at 10 mg/kg, i.p.) to adult C57BL/6J mice for 14 consecutive days, THEN we will observe significant stabilization of GABAergic parvalbumin-expressing hub neuron firing patterns in layer V motor cortex, as measured by reduc
Predicted outcome: ≥30% reduction in firing variability (CV-ISI) of GABAergic hub neurons in α5 inverse agonist-treated mice relative to vehicle-treated controls after 1
Falsification: No statistically significant difference (p > 0.05) in firing pattern variability between α5 inverse agonist and vehicle groups, or increased variability indicating destabilization
pendingconf 55%
IF we perform chemogenetic inhibition (hM4Di) of GABAergic hub neurons specifically in the anterior cingulate cortex while concurrently administering an α5-subunit inverse agonist (RG1662, 20 mg/kg/day via osmotic pump), THEN we will observe restoration of impaired functional connectivity between AC
Predicted outcome: Partial restoration (≥40%) of ACC-centered functional connectivity metrics to non-stressed baseline levels within 3 weeks of combined intervention, as
Falsification: Functional connectivity between ACC and default mode network nodes remains ≥70% below non-stressed baseline despite combined hub inhibition and α5 inverse agonist treatment, indicating inability to re
▸Metadatasource: v1_phase_c_backfill · origin_type: gap_debate
| source | v1_phase_c_backfill |
| origin_type | gap_debate |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.